Pfizer Expects Its Jab to Hold Up in Tests Vs. Omicron

The transcript discusses the effectiveness of vaccines against the Omicron variant, emphasizing the importance of booster programs to enhance immune response and coverage. It highlights ongoing experiments to assess vaccine effectiveness and the potential need for new vaccines. The discussion also covers the logistics of vaccine supply, decision-making processes, and the safety of mixing different vaccines. Pfizer's preparedness and collaboration with health authorities are also mentioned.

How does the effectiveness of vaccines against hospitalization compare to effectiveness against infection?

What is the significance of the 90% effectiveness reported after the booster dose?

What role do global surveillance sites play in monitoring vaccine effectiveness?